SAN DIEGO & SEOUL, South Korea--(BUSINESS WIRE)--A research consortium led by Samsung Medical Center, Seoul St. Mary's Hospital and bioinformatics partner Inocras Inc. has published the most comprehensive whole-genome breast cancer study of its kind in Nature. Using Inocras's proprietary whole-genome analysis platform CancerVisionâ"¢, the team analyzed 1,364 breast cancer genomes, together with transcriptomic data and matched clinical records. With more than 10.9 million somatic mutations mapped,. ...